+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 100Years
All Genders
ID05317858

Evaluating Safety and Effectiveness of Exablate Focused Ultrasound to Open the Blood-Brain Barrier During Immune Checkpoint Inhibitor Therapy for NSCLC Brain Metastases

Led by InSightec · Updated on 2026-10-13

96

Participants Needed

16

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of targeted blood-brain barrier opening using the Exablate Model 4000 Type 2 device in patients with brain metastases from non-small cell lung cancer NSCLC. This study focuses on patients receiving planned FDA-approved immune checkpoint inhibitor ICI systemic therapy for their primary NSCLC. The goal is to determine if adding the Exablate treatment improves the objective response rate of brain metastases compared to standard care alone. Participants are divided into two groups one receiving the Exablate blood-brain barrier opening combined with ICI therapy, and a control group receiving only the standard ICI systemic therapy. Immunotherapy is given every three weeks for six cycles according to approved guidelines. The Exablate procedure involves opening the blood-brain barrier on the day of ICI infusion to target brain metastases. The study is conducted at multiple centers across the US and lasts for up to six months of follow-up after treatment. During the trial, participants undergo MRI scans to monitor tumor lesions in the brain and assessments of adverse events. Researchers evaluate tumor responses using neuro-oncology criteria and track the time to response. Safety is closely monitored throughout the six-month period. Participants provide informed consent and are assessed for eligibility before joining. The study aims to provide detailed information on treatment effects and safety for patients with NSCLC brain metastases receiving immunotherapy.

CONDITIONS

Brief Title

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Research Team

A

Alyssa Voelker-Christy

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here